Literature DB >> 497332

General right censoring and its impact on the analysis of survival data.

S W Lagakos.   

Abstract

This paper concerns general right censoring and some of the difficulties it creates in the analysis of survival data. A general formulation of censored-survival processes leads to the partition of all models into those based on noninformative and informative censoring. Nearly all statistical methods for censored data assume that censoring is noninformative. Topics considered within this class include: the relationships between three models for noninformative censoring, the use of likelihood methods for inferences about the distribution of survival time, the effects of censoring on the K-sample problem, and the effects of censoring on model testing. Also considered are several topics which relate to informative censoring models. These include: problems of nonidentifiability that can be encountered when attempting to assess a set of data for the type of censoring in effect, the consequences of falsely assuming that censoring is noninformative, and classes of informative censoring models.

Mesh:

Year:  1979        PMID: 497332

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  17 in total

1.  Modeling the effects of genetic factors on late-onset diseases in cohort studies.

Authors:  Mark E Glickman; David R Gagnon
Journal:  Lifetime Data Anal       Date:  2002-09       Impact factor: 1.588

2.  Analysis of survival data with multiple causes of failure: a comparison of hazard- and logistic-regression models with application in demography.

Authors:  G Ghilagaber
Journal:  Qual Quant       Date:  1998-08

Review 3.  Statistical methods for dependent competing risks.

Authors:  M L Moeschberger; J P Klein
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

4.  A three-state disease model with interval-censored data: estimation and applications to AIDS and cancer.

Authors:  K M Leung; R M Elashoff
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

5.  Robust estimation for panel count data with informative observation times and censoring times.

Authors:  Hangjin Jiang; Wen Su; Xingqiu Zhao
Journal:  Lifetime Data Anal       Date:  2018-12-12       Impact factor: 1.588

6.  Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trials.

Authors:  Federico Campigotto; Edie Weller
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

7.  Repeat Kidney Transplantation After Failed First Transplant in Childhood: Past Performance Informs Future Performance.

Authors:  Meera Gupta; Alexander Wood; Nandita Mitra; Susan L Furth; Peter L Abt; Matthew H Levine
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

8.  Assessing long-term sustainment of clinic participation in NIATx200: Results and a new methodological approach.

Authors:  James H Ford; Scott P Stumbo; James M Robinson
Journal:  J Subst Abuse Treat       Date:  2018-06-27

9.  A flexible nonlinear mixed effects model for HIV viral load rebound after treatment interruption.

Authors:  Rui Wang; Ante Bing; Cathy Wang; Yuchen Hu; Ronald J Bosch; Victor DeGruttola
Journal:  Stat Med       Date:  2020-04-15       Impact factor: 2.373

10.  Measuring and Analyzing Length of Stay in Critical Care Trials.

Authors:  Michael O Harhay; Sarah J Ratcliffe; Dylan S Small; Leah H Suttner; Michael J Crowther; Scott D Halpern
Journal:  Med Care       Date:  2019-09       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.